Carcinoembryonic antigen 54.8ug/L suggests abnormality, and its assessment of the severity of the disease can not be judged by a single result, but requires multiple tests, dynamic observation and combined with the results of other tests to make a comprehensive judgment.
Carcinoembryonic antigen is a polysaccharide-rich protein complex with the ability to synthesize it in the gastrointestinal tract and certain tissues of the fetus in the early stages of life, but it gradually decreases after the 6th month of gestation, and the level of the substance after birth is as low as <2.5ug/L in non-smoking healthy patients.
The substance is usually used as a tumor marker, and is mostly used in the clinic to assist in the diagnosis of malignant tumors, monitoring of therapeutic efficacy, and other situations. Elevated may be pancreatic cancer, colon cancer, rectal cancer and other related diseases. Dynamic observation is needed to assess the severity of the disease, and if the test continues to be elevated for several times, it may indicate that the disease is worsening. It is important to note that some chronic inflammatory diseases and heavy chronic smokers may also have mild elevations.
If the laboratory test indicates abnormal carcinoembryonic antigen, it is recommended to go to a regular hospital in time to improve the examination and clarify the cause of the disease to avoid delaying the condition.